Eric Weisblum - Apr 15, 2019 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role
CEO, CFO and President, Director
Signature
/s/ Eric Weisblum
Stock symbol
SILO
Transactions as of
Apr 15, 2019
Transactions value $
$281
Form type
4
Date filed
5/17/2021, 07:31 AM
Next filing
May 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILO Common Stock Purchase $115 +57.7K $0.00* 57.7K Jun 17, 2019 Direct
transaction SILO Common Stock Purchase $76.00 +200 +0.35% $0.38 57.9K Oct 15, 2019 Direct
transaction SILO Common Stock Purchase $90.00 +200 +0.35% $0.45 58.1K Oct 22, 2019 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILO Stock Option (right to buy) Award $0 +100K $0.00 100K Apr 15, 2019 Common Stock 100K $0.00 Direct F1
transaction SILO Stock Option (right to buy) Award $0 +100K $0.00 100K Apr 15, 2019 Common Stock 100K $0.00 Direct F1, F2
transaction SILO Stock Option (right to buy) Award $0 +100K $0.00 100K Oct 15, 2019 Common Stock 100K $0.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019.
F2 The options were granted on April 15, 2019 and vested in full on July 15, 2019.